Agile Therapeutics, Inc. (AGRX)
Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)
1.510
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2024
Agile Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
| 10 | 10 | 2 | 5 | 5 | 3 | 10 | 9 | 12 | 14 | 28 | 59 | 89 | 117 | 182 | 251 | 265 | 242 | 158 | 148 | 70 | |
Market Cap Growth (YoY) | - | 218.43% | -77.64% | -46.88% | -60.09% | -78.86% | -63.04% | -84.44% | -87.04% | -87.73% | -84.53% | -76.39% | -66.32% | -51.58% | 15.54% | 69.26% | 277.67% | 279.64% | 141.75% | 648.87% | 457.74% |
Enterprise Value | 8 | 7 | 2 | 5 | 5 | 1 | 7 | 5 | 12 | 25 | 27 | 61 | 74 | 93 | 144 | 195 | 194 | 164 | 123 | 130 | 60 |
Last Close Price | 1.51 | 1.41 | 0.34 | 1.95 | 2.40 | 2.95 | 11.20 | 11.35 | 14.85 | 58.25 | 419.00 | 976.20 | 1922.20 | 2660.00 | 4160.00 | 5740.00 | 6080.00 | 5560.00 | 3720.00 | 5000.00 | 2370.00 |
Price Ratios
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
PE Ratio | - | -0.44 | -0.09 | -0.20 | -0.18 | -0.14 | -0.15 | -0.05 | -0.03 | -0.06 | -0.33 | -0.66 | -1.24 | -1.71 | -2.97 | -4.72 | -6.04 | -6.85 | -5.15 | -6.52 | -2.98 |
PS Ratio | 0.31 | 0.45 | 0.11 | 0.25 | 0.23 | 0.19 | 0.81 | 0.85 | 1.38 | 2.15 | 4.91 | 14.44 | 26.78 | 57.26 | 210.71 | 335.03 | - | - | - | - | - |
PB Ratio | - | -0.44 | -0.23 | -0.30 | -0.37 | -0.25 | -1.10 | -1.66 | 1.85 | 4.21 | 10.28 | 15.13 | 8.37 | 4.77 | 5.20 | 5.09 | 4.01 | 3.00 | 1.74 | 3.24 | 2.20 |
P/FCF Ratio | - | -5.68 | -0.22 | -0.51 | -0.41 | -0.11 | -0.46 | -0.26 | -0.23 | -0.27 | -0.43 | -0.91 | -1.35 | -1.86 | -3.35 | -5.26 | -7.90 | -10.40 | -8.36 | -9.39 | -4.51 |
P/OCF Ratio | - | -5.68 | -0.22 | -0.51 | -0.41 | -0.11 | -0.46 | -0.26 | -0.23 | -0.27 | -0.43 | -0.91 | -1.36 | -1.87 | -3.37 | -5.30 | -7.98 | -10.54 | -8.48 | -9.45 | -4.52 |
EV Ratios
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
EV/Sales Ratio | 0.36 | 0.35 | 0.09 | 0.23 | 0.23 | 0.05 | 0.57 | 0.48 | 1.43 | 3.70 | 4.67 | 14.87 | 22.29 | 45.38 | 166.84 | 260.54 | - | - | - | - | - |
EV/EBITDA Ratio | - | -0.57 | -0.13 | -0.23 | -0.20 | -0.03 | -0.23 | -0.13 | -0.22 | -0.39 | -0.39 | -0.89 | -1.17 | -1.48 | -2.54 | -4.00 | -5.07 | -5.84 | -5.71 | -6.96 | -3.73 |
EV/EBIT Ratio | - | -0.55 | -0.12 | -0.23 | -0.20 | -0.03 | -0.23 | -0.13 | -0.21 | -0.38 | -0.38 | -0.86 | -1.14 | -1.45 | -2.50 | -3.98 | -5.05 | -5.81 | -5.67 | -6.90 | -3.71 |
EV/FCF Ratio | - | -4.37 | -0.19 | -0.47 | -0.40 | -0.03 | -0.32 | -0.14 | -0.24 | -0.47 | -0.41 | -0.93 | -1.12 | -1.48 | -2.66 | -4.09 | -5.77 | -7.04 | -6.54 | -8.24 | -3.85 |
Financial Efficiency
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
Debt / Equity Ratio | -0.01 | -0.01 | -0.04 | -0.13 | -0.20 | -0.22 | -0.23 | -0.40 | 0.34 | 3.95 | 4.81 | 4.54 | 1.54 | 0.65 | 0.45 | 0.33 | 0.24 | 0.20 | 0.17 | 0.00 | 0.01 |
Debt / FCF Ratio | -0.17 | -0.17 | -0.04 | -0.23 | -0.22 | -0.09 | -0.10 | -0.06 | -0.04 | -0.25 | -0.20 | -0.27 | -0.25 | -0.26 | -0.29 | -0.35 | -0.48 | -0.68 | -0.83 | -0.01 | -0.01 |
Asset Turnover | 1.62 | 2.00 | 1.37 | 2.27 | 1.68 | 1.09 | 0.98 | 0.47 | 0.27 | 0.21 | 0.16 | 0.12 | 0.08 | 0.01 | 0.04 | - | - | - | - | - | |
Inventory Turnover | 1.88 | 1.25 | 2.07 | 3.40 | 4.00 | 3.89 | 4.52 | 4.23 | 2.76 | 3.55 | 3.34 | 10.30 | 3.13 | 1.81 | - | - | - | - | - | - | - |
Quick Ratio | 0.28 | 0.28 | 0.35 | 0.29 | 0.36 | 0.47 | 0.41 | 0.64 | 0.85 | 0.53 | 0.39 | 0.71 | 1.68 | 2.77 | 4.60 | 7.53 | 9.98 | 13.44 | 33.45 | 9.09 | 9.69 |
Current Ratio | 0.55 | 0.55 | 0.56 | 0.46 | 0.57 | 0.76 | 0.59 | 0.85 | 1.33 | 0.64 | 0.56 | 0.82 | 2.27 | 3.18 | 4.97 | 7.72 | 10.18 | 13.67 | 33.69 | 9.31 | 10.39 |
Return on Equity (ROE) | - | - | - | - | - | - | -4398.32% | -490.13% | -670.95% | -1247.82% | -1070.50% | -380.22% | -236.49% | -162.39% | -122.09% | -84.53% | -50.53% | -46.25% | -62.03% | -64.50% | |
Return on Assets (ROA) | -49.79% | -60.29% | -95.82% | -85.25% | -97.57% | -120.05% | -105.15% | -73.95% | -91.73% | -113.45% | -147.06% | -88.66% | -74.50% | -61.20% | -51.52% | -38.07% | -23.68% | -24.04% | -36.61% | -38.29% | |
Return on Invested Capital (ROIC) | - | - | - | - | - | - | -678.17% | -149.78% | -173.47% | -206.86% | -228.81% | -116.21% | -90.98% | -69.54% | -56.52% | -40.96% | -24.74% | -25.04% | -39.12% | -40.58% |
Yields
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
Earnings Yield | -152.10% | -163.56% | -334.35% | -295.40% | -301.26% | -626.05% | -195.87% | -275.66% | -353.99% | -360.11% | -228.08% | -119.94% | -77.37% | -57.85% | -33.52% | -20.66% | -15.17% | -12.03% | -13.83% | -12.55% | -23.33% |
FCF Yield | -16.36% | -17.60% | -448.63% | -195.54% | -244.57% | -932.04% | -218.69% | -391.34% | -441.86% | -369.01% | -232.64% | -110.49% | -74.06% | -53.62% | -29.82% | -18.99% | -12.66% | -9.62% | -11.96% | -10.65% | -22.18% |
Buyback Yield / Dilution | -308.85% | -287.40% | -407.86% | -259.38% | -298.69% | -1862.00% | -1363.86% | -1298.69% | -1478.44% | -103.40% | -42.20% | -34.84% | -7.34% | -1.69% | -14.32% | -39.78% | -62.94% | -99.25% | -105.46% | -81.98% | -55.94% |
Total Shareholder Return | -308.85% | -287.40% | -407.86% | -259.38% | -298.69% | -1862.00% | -1363.86% | -1298.69% | -1478.44% | -103.40% | -42.20% | -34.84% | -7.34% | -1.69% | -14.32% | -39.78% | -62.94% | -99.25% | -105.46% | -81.98% | -55.94% |